Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT03783442
Brief Title: A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

First Submitted : December 18, 2018
First Submitted that Met QC Criteria : December 19, 2018
First Posted : December 21, 2018

Last Update Submitted that Met QC Criteria : April 26, 2022
Last Update Posted : May 2, 2022